Glycoprotein 130 regulates cardiac myocyte survival in doxorubicin-induced apoptosis through phosphatidylinositol 3-kinase/Akt phosphorylation and Bcl-xL/caspase-3 interaction

Circulation

Volumn 103, Issue 4, 2001, Pages 555-561

  Negoro, Shinji ^a,b   Oh, Hidemasa ^a,b   Tone, Eiroh ^a,b   Kunisada, Keita ^a,b   Fujio, Yasushi ^a,b   Walsh, Kenneth ^a,b   Kishimoto, Tadamitsu ^a,b   Yamauchi Takihara, Keiko ^a,b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Caspases; Doxorubicin; Glycoproteins; Kinases

Indexed keywords

CASPASE 3; CASPASE 9; CASPASE INHIBITOR; DOXORUBICIN; GLYCOPROTEIN GP 130; LEUKEMIA INHIBITORY FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL KINASE; PROTEIN BAD; PROTEIN BCL X; PROTEIN BCL XL; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROTECTION; CELL SURVIVAL; CELL VIABILITY; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; HEART MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0035970041     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.4.555     Document Type: Article

References (27)

1. Cardiotrophin-1: Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex
2. Signals through gp130 upregulate bcl-x gene expression via STAT1-binding cis-element in cardiac myocytes
3. Cardiotrophin-1 displays early expression in the murine heart tube and promotes cardiac myocyte survival
4. Activation of phosphatidylinositol 3-kinase through glycoprotein 130 induces protein kinase B and p70 S6 kinase phosphorylation in cardiac myocytes
5. Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase
6. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor
7. Regulation of neuronal survival by the serine-threonine protein kinase Akt
8. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor
9. Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces Bax and promotes cell death
10. Activation of the CPP32 apoptotic protease by distinct signaling pathways with differential sensitivity to Bcl-xL
11. Early and delayed clinical cardiotoxicity of doxorubicin
12. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress
13. Stress pathways and heart failure
14. Hypoxic stress induces cardiac myocyte-derived interleukin-6
15. Cell density-dependent apoptosis in HL-60 cells, which is mediated by an unknown soluble factor, is inhibited by transforming growth factor β1 and overexpression of Bcl-2
16. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
17. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart
18. Doxombicin-induced apoptosis in spontaneously hypertensive rats: Differential effects in heart, kidney and intestine, and inhibition by ICRF-187
19. Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor I
20. Daunorubicin-induced apoptosis in rat cardiac myocytes is inhibited by dexrazoxane
21. Overexpression of Bcl-xL inhibits Ara-C-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis
22. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells
23. Conversion of Bcl-2 to a Bax-like death effector by caspases
24. Modulation of cell death by Bcl-xL through caspase interaction
25. Regulation of cell death protease caspase-9 by phosphorylation
26. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt
27. Bcl-2 targets the protein kinase Raf-1 to mitochondria